I was surprised to come across this private company doing a clinical study on the use of 5-MeO-DMT for treating treatment-resistant depression. It looks like they're seeking to patent a certain Route of Administration. No mention of it being an adjunct to psychotherapy.
https://www.ghres.com/pipeline (https://www.ghres.com/pipeline)
GH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress (https://www.prnewswire.co.uk/news-releases/gh-research-ltd-announces-completion-of-phase-1-clinical-study-with-gh001-5-methoxy-n-n-dimethyltryptamine-in-healthy-volunteers-and-updates-on-further-progress-843609682.html)
Super interesting!! Thanks for sharing.
OMG I was so naive... apparently there's a fair bit of this kind of thing going on.
https://www.vice.com/en/article/7k9359/the-race-to-patent-psychedelics-is-just-getting-started (https://www.vice.com/en/article/7k9359/the-race-to-patent-psychedelics-is-just-getting-started)
Yes, unfortunately this sort of thing is happening all over the place.